Quarterly Result29 May 2026, 01:58 pm
Ipca Labs Q4FY26: Dividend of ₹6/Share Recommended
AI Summary
Ipca Laboratories Ltd has announced its Standalone and Consolidated Results for Q4FY26. The Board of Directors has recommended a dividend of ₹6 per share (600%) subject to shareholder approval, with a record date fixed as August 7, 2026. Additionally, the board approved the re-appointment of Mr. Prashant Godha as Executive Director for another 5 years effective August 16, 2026, also subject to shareholder approval. Standalone revenue from operations for the year ended March 31, 2026, stood at ₹7,336.75 Cr.
Key Highlights
- Ipca Labs Board recommends a dividend of ₹6 per share (600%) for FY26.
- Record date for dividend entitlement is fixed as August 7, 2026, subject to approval.
- Prashant Godha re-appointed as Executive Director for 5 years, effective August 16, 2026.
- Standalone revenue from operations for FY26 is ₹7,336.75 Cr.
- Board meeting was held on April 27, 2026, concluding at 1.45 p.m.
Price Impact
More from IPCALAB